FDA approves Tymlos for postmenopausal women with osteoporosis at high risk for fracture May 3, 2017 No Comments
FDA grants accelerated approval to Imfinzi for previously treated bladder cancer May 2, 2017 No Comments
FDA approves Stivarga for second-line treatment of hepatocellular carcinoma April 28, 2017 No Comments
FDA grants accelerated approval to Tecentriq for bladder cancer not treatable with cisplatin April 18, 2017 No Comments
FDA grants approval for Ingrezza capsules for adults with tardive dyskinesia April 12, 2017 No Comments
RSS